« St. Jude Medical Announces FDA Approval of Next Generation Internet-Based | Main | FDA Approvals - St. Jude Medical Announces FDA Approval of Next Generation Internet-Based »

FDA Approves New Genetic Test for Breast Cancer Patients The


FDA Approves New Genetic Test for Breast Cancer Patients
The U.S. Food and Drug Administration has approved a test that helps in assessing the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer. The TOP2A FISH pharmDx is the first approved device to test for the TOP2A (topoisomerase 2 alpha) gene in cancer patients.
 

©2006 FDA-News.com. All rights reserved.